Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Celltrion HealthCare Co Ltd (091990)

KOSDAQ
Currency in KRW
Disclaimer
75,900
0(0.00%)
Closed
091990 Scorecard
Fair Value
Unlock Value
Day's Range
75,10080,800
52 wk Range
53,60081,400
Bid/Ask
75,900.00 / 76,000.00
Prev. Close
80,400
Open
80,700
Day's Range
75,100-80,800
52 wk Range
53,600-81,400
Volume
0
Average Volume (3m)
394,243
1-Year Change
10.64%
Shares Outstanding
156,883,373
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More

People Also Watch

91,900
068760
+0.66%
179,500
068270
-0.11%
245,500
247540
+5.14%
396,000
005490
+1.15%
183,700
035420
+2.00%
How do you feel today about 091990?
Vote to see community's results!
or

Celltrion HealthCare Company Profile

Celltrion Healthcare Co., Ltd. operates a biopharmaceutical company in South Korea and internationally. Its biosimilar products include Remsima, Yuflyma, and Remsima SC, which are used for rheumatoid arthritis and inflammatory bowel diseases; Truxima that is used for non-hodgkin’s lymphoma, chronic lymphocytic leukemia, etc.; Herzuma, which is used for metastatic breast and metastatic gastric cancer; and Vegzelma for metastatic colorectal and non-small cell lung cancer. The company also provides novel therapeutics, such as Zymfentra that is used to treat inflammatory bowel disease; and Regkirona for the treatment of COVID-19. In addition, it offers small molecules products for tuberculosis, rare epilepsy, HIV/AIDS, and COVID-19, as well as test kits for COVID-19. The company was formerly known as Nexol, Inc. and changed its name to Celltrion Healthcare Co., Ltd. in March 2009. Celltrion Healthcare Co., Ltd. was founded in 1999 and is headquartered in Incheon, South Korea. Celltrion Healthcare Co., Ltd. is a subsidiary of Celltrion, Inc.

Employees
120
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.